|

NAs Clinical Trials

2 actively recruiting trials

▼ -1 trial since June 2026

Also known as: ETV/TDF/TAF

Pipeline

Phase 2: 2

Top Sponsors

  • The Second Affiliated Hospital of Chongqing Medical University2

Indications

Other2 trials

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
Phase 2
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.